Free Trial

Aardvark Therapeutics (AARD) Institutional Ownership

Aardvark Therapeutics logo
$10.01 -1.11 (-9.98%)
As of 05/22/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Aardvark Therapeutics (NASDAQ:AARD)

Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$41.30M
Number of
Institutional Sellers
(last 12 months)
0
Get AARD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aardvark Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

AARD Institutional Buying and Selling by Quarter

Aardvark Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025 Goldman Sachs Group Inc.20,311$153K0.0%N/A0.094%
5/16/2025 Cormorant Asset Management LP800,189$6.01M0.5%N/A3.688%
5/16/2025 Adage Capital Partners GP L.L.C.250,000$1.88M0.0%N/A1.152%
5/15/2025 Braidwell LP500,000$3.76M0.1%N/A2.305%
5/14/2025 Walleye Capital LLC11,730$88K0.0%N/A0.054%
5/8/2025 Decheng Capital LLC3,917,299$29.42M8.3%N/A18.055%
(Data available from 1/1/2016 forward)

AARD Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AARD shares?

During the previous two years, the following institutional investors and hedge funds held shares of Aardvark Therapeutics shares: Decheng Capital LLC ($29.42M), Cormorant Asset Management LP ($6.01M), Braidwell LP ($3.76M), Adage Capital Partners GP L.L.C. ($1.88M), and Goldman Sachs Group Inc. ($153K), Walleye Capital LLC ($88K).Learn more on AARD's institutional investors.

Which institutional investors have been buying Aardvark Therapeutics stock?

The following institutional investors have purchased Aardvark Therapeutics stock in the last 24 months: Decheng Capital LLC ($3.92M), Cormorant Asset Management LP ($800.19K), Braidwell LP ($500K), Adage Capital Partners GP L.L.C. ($250K), Goldman Sachs Group Inc. ($20.31K), and Walleye Capital LLC ($11.73K).

How much institutional buying is happening at Aardvark Therapeutics?

Institutional investors have bought a total of 5,499,529 shares in the last 24 months. This purchase volume represents approximately $41.30M in transactions.



This page (NASDAQ:AARD) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners